NPI: 1992464697 · STERLING HEIGHTS, MI 48314 · Urgent Care Clinic/Center · NPI assigned 12/10/2021
Authorized official MOLNAR, NANCY controls 20+ related entities in our dataset. Read more
| Authorized Official | MOLNAR, NANCY (BUSINESS OPERATIONS MANAGER) |
| NPI Enumeration Date | 12/10/2021 |
Other providers sharing the same authorized official: MOLNAR, NANCY
| Year | Claims | Total Paid |
|---|---|---|
| 2023 | 2,183 | $95K |
| 2024 | 2,006 | $92K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 643 | 606 | $49K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 464 | 461 | $44K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 540 | 517 | $32K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 415 | 415 | $29K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 410 | 389 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 551 | 271 | $7K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 74 | 73 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 355 | 346 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 95 | 94 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 65 | 65 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 33 | 33 | $993.54 |
| 87428 | 34 | 33 | $717.36 | |
| 99000 | 495 | 468 | $72.89 | |
| 81002 | 15 | 13 | $37.44 |